We're Not Very Worried About Veritas In Silico's (TSE:130A) Cash Burn Rate
Apr 14
Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Clinical Research and Equipment Industry Analysis
UpdatedMay 01, 2026
DataAggregated Company Financials
Companies14
- 7D-2.1%
- 3M-8.6%
- 1Y-6.4%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 3.9%, driven by Immuno-Biological Laboratories declining 8.8%. Over the last year, the industry has been flat overall. Looking forward, earnings are forecast to grow by 12% annually.
Industry Valuation and Performance
Has the Japanese Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 01 May 2026 | JP¥137.9b | JP¥63.3b | -JP¥864,496,000.00 | 22.3x | -159.5x | 2.2x |
| Sun, 29 Mar 2026 | JP¥141.0b | JP¥63.3b | -JP¥864,966,000.00 | 21.5x | -163x | 2.2x |
| Tue, 24 Feb 2026 | JP¥156.6b | JP¥63.2b | -JP¥944,048,000.00 | 23.2x | -165.9x | 2.5x |
| Thu, 22 Jan 2026 | JP¥150.8b | JP¥66.9b | JP¥72.2m | 23.3x | 2089.6x | 2.3x |
| Sat, 20 Dec 2025 | JP¥155.9b | JP¥66.9b | JP¥72.2m | 20.2x | 2159.1x | 2.3x |
| Mon, 17 Nov 2025 | JP¥138.5b | JP¥67.5b | JP¥834.9m | 17.7x | 165.9x | 2.1x |
| Wed, 15 Oct 2025 | JP¥138.9b | JP¥66.5b | JP¥1.5b | 16x | 95.2x | 2.1x |
| Fri, 12 Sep 2025 | JP¥147.2b | JP¥66.5b | JP¥1.5b | 16.7x | 100.9x | 2.2x |
| Sun, 10 Aug 2025 | JP¥141.3b | JP¥66.9b | JP¥1.3b | 16.6x | 106.2x | 2.1x |
| Tue, 08 Jul 2025 | JP¥140.3b | JP¥66.0b | JP¥1.1b | 16x | 124.2x | 2.1x |
| Thu, 05 Jun 2025 | JP¥138.6b | JP¥66.0b | JP¥1.1b | 17.6x | 122.3x | 2.1x |
| Sat, 03 May 2025 | JP¥143.7b | JP¥64.2b | JP¥1.5b | 14.8x | 93.5x | 2.2x |
| Mon, 31 Mar 2025 | JP¥157.4b | JP¥64.8b | JP¥927.4m | 15.4x | 169.7x | 2.4x |
| Wed, 26 Feb 2025 | JP¥163.2b | JP¥65.1b | JP¥1.1b | 15.8x | 146.2x | 2.5x |
| Fri, 24 Jan 2025 | JP¥159.1b | JP¥62.0b | JP¥440.7m | 17.6x | 361x | 2.6x |
| Sun, 22 Dec 2024 | JP¥158.3b | JP¥62.0b | JP¥440.7m | 17.1x | 359.1x | 2.6x |
| Tue, 19 Nov 2024 | JP¥151.7b | JP¥62.6b | JP¥1.3b | 19.6x | 113.7x | 2.4x |
| Thu, 17 Oct 2024 | JP¥151.4b | JP¥61.5b | JP¥1.8b | 21.1x | 82.2x | 2.5x |
| Sat, 14 Sep 2024 | JP¥154.3b | JP¥61.6b | JP¥2.1b | 18.3x | 74.7x | 2.5x |
| Mon, 12 Aug 2024 | JP¥140.9b | JP¥61.5b | JP¥2.0b | 19x | 69.6x | 2.3x |
| Wed, 10 Jul 2024 | JP¥164.2b | JP¥61.8b | JP¥3.2b | 25.8x | 50.7x | 2.7x |
| Fri, 07 Jun 2024 | JP¥161.3b | JP¥61.8b | JP¥3.3b | 24.8x | 49.3x | 2.6x |
| Sun, 05 May 2024 | JP¥182.6b | JP¥62.3b | JP¥3.3b | 14x | 55.5x | 2.9x |
| Tue, 02 Apr 2024 | JP¥232.9b | JP¥155.4b | JP¥8.6b | 13.9x | 27x | 1.5x |
| Thu, 29 Feb 2024 | JP¥238.7b | JP¥155.3b | JP¥8.7b | 14.4x | 27.5x | 1.5x |
| Sat, 27 Jan 2024 | JP¥226.8b | JP¥167.1b | JP¥8.5b | 15.3x | 26.7x | 1.4x |
| Mon, 25 Dec 2023 | JP¥222.2b | JP¥167.1b | JP¥8.5b | 14.8x | 26.1x | 1.3x |
| Wed, 22 Nov 2023 | JP¥236.4b | JP¥167.4b | JP¥8.7b | 15x | 27.2x | 1.4x |
| Fri, 20 Oct 2023 | JP¥229.0b | JP¥179.3b | JP¥12.8b | 14.3x | 17.9x | 1.3x |
| Sun, 17 Sep 2023 | JP¥254.7b | JP¥179.3b | JP¥12.8b | 15.5x | 19.9x | 1.4x |
| Tue, 15 Aug 2023 | JP¥269.7b | JP¥180.0b | JP¥13.7b | 16.8x | 19.6x | 1.5x |
| Thu, 13 Jul 2023 | JP¥272.4b | JP¥178.5b | JP¥16.2b | 16.5x | 16.8x | 1.5x |
| Sat, 10 Jun 2023 | JP¥281.8b | JP¥178.3b | JP¥16.2b | 16.8x | 17.4x | 1.6x |
| Mon, 08 May 2023 | JP¥288.7b | JP¥174.9b | JP¥16.5b | 16.6x | 17.5x | 1.7x |
Price to Earnings Ratio
17.5x
Current Industry PE
- Investors are relatively neutral on the Japanese Life Sciences Tools and Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 2.1x.
Past Earnings Growth
- Total earnings for the Life Sciences Tools and Services industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 29% per year, which is driving profits down.
Industry Comparison
How does Japanese Clinical Research and Equipment compare with similar industries?
| JP Market | 0.22% | |
| Healthcare | -2.78% | |
| Life Sciences | -2.06% | |
| Clinical Research and Equipment | -2.06% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4583 Chiome Bioscience | JP¥102.00 | 2.0% +JP¥141.8m | -23.9% | PS12.2x | |
| 4241 atect | JP¥757.00 | 2.3% +JP¥75.2m | 101.9% | PE25.4x | |
| 130A Veritas In Silico | JP¥471.00 | 1.5% +JP¥45.4m | -30.0% | PS33.5x | |
| 4880 CellSource | JP¥370.00 | 0.5% +JP¥39.7m | -43.2% | PE82.4x | |
| 7079 WDB coco | JP¥2.62k | 0.3% +JP¥21.6m | -23.5% | PE8.9x |